Literature DB >> 3006256

New human T-lymphotropic retrovirus related to simian T-lymphotropic virus type III (STLV-IIIAGM).

P J Kanki, F Barin, S M'Boup, J S Allan, J L Romet-Lemonne, R Marlink, M F McLane, T H Lee, B Arbeille, F Denis.   

Abstract

This report describes serologic evidence for a virus similar to that known as simian T-lymphotropic virus type III of African Green monkeys (STLV-IIIAGM) infecting apparently healthy people in Senegal, West Africa, and the isolation of virus from these individuals. Serum samples from selected healthy West African people showed unusual serologic profiles when tested with antigens of HTLV-III/LAV, the etiologic agent of AIDS, and of STLV-IIIAGM. The samples reacted strongly with all of the major viral antigens of STLV-IIIAGM but showed variable or no reactivity with the major viral antigens of HTLV-III/LAV by radioimmunoprecipitation and sodium dodecyl sulfate-polyacrylamide gel electrophoresis. A new human T-lymphotropic virus (HTLV-IV) isolated from these people was grown in vitro and shown to have retroviral type particles, growth characteristics, and major viral proteins similar to those of the STLV-III and HTLV-III/LAV group of retroviruses. The gp120/160, gp32, p64, p55, p53, p24, and p15 proteins precipitated were the same size as and reactive with STLV-IIIAGM proteins. The serologic data suggest that this virus shares more common epitopes with STLV-IIIAGM than with the prototype HTLV-III/LAV that infects people in the United States and Europe. Further study of this virus and of the origin of the HTLV-III/LAV group of viruses may expand our understanding of the human AIDS virus.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3006256     DOI: 10.1126/science.3006256

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  40 in total

1.  HIV-2 antibody testing of blood donors with doubtful immunoblot results for HIV-1.

Authors:  J Knüver-Hopf; H Mohr; J Beyer; B Lambrecht; D Mix; H Rübsamen-Waigmann; H Schmitt
Journal:  Blut       Date:  1989-03

2.  Location, exposure, and conservation of neutralizing and nonneutralizing epitopes on human immunodeficiency virus type 2 SU glycoprotein.

Authors:  A McKnight; C Shotton; J Cordell; I Jones; G Simmons; P R Clapham
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

Review 3.  Human retroviruses and paediatric disease.

Authors:  B J Thomson; A G Dalgleish
Journal:  Arch Dis Child       Date:  1987-06       Impact factor: 3.791

4.  95- and 25-kDa fragments of the human immunodeficiency virus envelope glycoprotein gp120 bind to the CD4 receptor.

Authors:  A Nygren; T Bergman; T Matthews; H Jörnvall; H Wigzell
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

5.  Envelope cross-reactivity between human immunodeficiency virus types 1 and 2 detected by different serological methods: correlation between cross-neutralization and reactivity against the main neutralizing site.

Authors:  B Böttiger; A Karlsson; P A Andreasson; A Nauclér; C M Costa; E Norrby; G Biberfeld
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

6.  Epidemiological correlations between African AIDS and AIDS in Europe.

Authors:  N Clumeck
Journal:  Infection       Date:  1986 May-Jun       Impact factor: 3.553

7.  HIV 1 and HIV 2 prevalence of seropositivity in a population of West Africa.

Authors:  N Zanchetta; P Viganò; G B Priuli; M P Ferrario; M Zago; A Pagano
Journal:  Eur J Epidemiol       Date:  1990-03       Impact factor: 8.082

8.  Identification of simian immunodeficiency virus SIVMAC env gene products.

Authors:  F D Veronese; B Joseph; T D Copeland; S Oroszlan; R C Gallo; M G Sarngadharan
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

9.  Genetic variability between isolates of human immunodeficiency virus (HIV) type 2 is comparable to the variability among HIV type 1.

Authors:  J F Zagury; G Franchini; M Reitz; E Collalti; B Starcich; L Hall; K Fargnoli; L Jagodzinski; H G Guo; F Laure
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

10.  Screening of African sera stored for more than 17 years for HIV antibodies by site-directed serology.

Authors:  F Chiodi; G Biberfeld; E Parks; E Norrby; M Mufson
Journal:  Eur J Epidemiol       Date:  1989-03       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.